EUVIMEDEUVIMED entdecken
Querschnittstudie

Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey

Riki Kurokawa iD, Sachiko Ohde, Satoshi Kawaai, Hiromichi Tamaki

Modern Rheumatology · 2025

DOI: 10.1093/mr/roae102 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Riki Kurokawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Public Health, St. Luke's International University, Tokyo, Japan. Hauptthemen laut MEDLINE: Rheumatic Diseases, COVID-19 Vaccines, COVID-19, Immunization, Secondary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We studied the current state and factors associated with the acceptance or hesitancy of booster doses of the coronavirus disease 2019 (COVID-19) vaccine among patients with autoimmune and rheumatic diseases (ARDs) in Japan.

Methods

A single-centre cross-sectional survey was conducted among outpatients with ARDs who visited the Immuno-Rheumatology Center at St. Luke’s International Hospital from 1 October 2023 to 30 November 2023. We investigated patient characteristics, COVID-19 vaccination–related status, decision-making preferences, health-related status, and independent factors associated with the acceptance or hesitancy of booster doses of the COVID-19 vaccine.

Results

A total of 241 patients were included in the analyses, and 198 patients (82.2%) received booster doses, while 43 (17.8%) did not. Older age [adjusted odds ratio (aOR) = 0.43, 95% confidence interval (CI): 0.19, 0.95, P = .037], having rheumatoid arthritis (aOR = 0.41, 95% CI: 0.19, 0.92, P = .030), and having a physician recommend receiving the vaccine (aOR = 0.47, 95% CI: 0.23, 0.95, P = .035) were independently associated with receiving booster doses. The main reasons for hesitancy regarding booster doses were concerns about adverse reactions and long-term safety.

Conclusions

Our findings could help physicians counsel patients with ARDs regarding their acceptance of COVID-19 vaccine booster doses to promote appropriate decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic DiseasesCOVID-19 VaccinesCOVID-19Immunization, SecondaryAutoimmune DiseasesVaccination HesitancyPatient Acceptance of Health CareHumansMaleFemaleCross-Sectional StudiesMiddle AgedAgedJapanAdultSARS-CoV-2

Stichwörter der Autor:innen

COVID-19Japanautoimmune diseasesrheumatic diseasesvaccination hesitancy

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Graduate School of Public Health, St. Luke's International University, Tokyo, Japan.
  • Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan.

ORCID-Profile: Riki Kurokawa

Zitieren

APA

Kurokawa, R., Ohde, S., Kawaai, S., & Tamaki, H. (2025). Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey. Modern Rheumatology. https://doi.org/10.1093/mr/roae102

Vancouver

Kurokawa R, Ohde S, Kawaai S, Tamaki H. Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey. Modern Rheumatology. 2025. doi:10.1093/mr/roae102

BibTeX
@article{Kurokawa2025,
  author = {Kurokawa, Riki and Ohde, Sachiko and Kawaai, Satoshi and Tamaki, Hiromichi},
  title = {Factors related to acceptance of COVID-19 vaccine booster doses among patients with autoimmune and rheumatic diseases in Japan: A single-centre cross-sectional survey},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roae102}
}
Kostenlos starten →